You are using an older browser version. Please use a supported version for the best MSN experience.

Experts say J&J vaccine will accelerate vaccination in the U.S.

The J&J Covid-19 vaccine has been shipped to states after the FDA approved it for emergency use authorization. The vaccine has 72 percent efficacy in the U.S. against moderate to severe disease. CNBC's Meg Tirrell joins 'The News with Shepard Smith' to report.
image beaconimage beaconimage beacon